Wang, Zhao
Kosheleff, Alisa R
Adeojo, Lilian W
Odebo, Oyinkansola
Liranso, Tesfaye
Schwabe, Stefan
Nasser, Azmi
Article History
Accepted: 30 September 2021
First Online: 15 October 2021
Declarations
:
: This trial was fully sponsored by Supernus Pharmaceuticals, Inc. The protocol was designed by Supernus employees and the study was conducted by Worldwide Clinical Trials.
: The data are not available in a repository, but reasonable requests can be directed to Azmi Nasser at anasser@supernus.com.
: Not applicable.
: A. Nasser, Z. Wang, A Kosheleff, L. Adeojo, O. Odebo, and T. Liranso are employees of Supernus Pharmaceuticals, Inc. S. Schwabe was an employee of Supernus Pharmaceuticals, Inc. at the time of this work.
: This trial was conducted in accordance with the Helsinki Declaration and the International Council for Harmonisation Note for Guidance on Good Clinical Practice. The trial conduct was reviewed and approved by IntegReview Institutional Review Board (Austin, TX, USA).
: Informed consent was obtained from all individual participants included in the study.
: Subjects provided and signed informed consent regarding the publication of their data.